AIMS: To evaluate the relationship between oxidative stress and endothelial dysfunction (ED) in diabetic patients without clinical macrovascular complications. METHODS: In 27 type 1, 56 type 2 diabetic patients and 35 healthy controls the redox state (GSH, GSSG; enzymatic method), endothelin-1 (ET-1; ELISA) and von Willebrand factor (vWF; ELISA) plasma levels, urinary vascular endothelial growth factor (VEGF; ELISA) were measured. RESULTS: Decreased GSH levels (p<0.05, type 1 and type 2), GSH/GSSG ratio (p<0.05 type 1, p<0.001 type 2) and elevated vWF levels (p<0.001, type 1 and type 2) were observed in diabetic patients in comparison with controls. A negative correlation between GSH and vWF (p<0.02 and p<0.001, in type 1 and type 2, respectively) and GSH and BMI (p<0.02 in type 1 and type 2) was observed. ET-1 was positively correlated to age (p<0.05) and diabetes duration (p<0.03) in type 1, while vWF was correlated to systolic blood pressure (p<0.05) in type 2 diabetic patients. Urinary VEGF was higher in type 2 (p<0.05) in comparison with type 1 diabetic patients and was correlated to glycemia (p<0.05) and systolic blood pressure (p<0.05). CONCLUSIONS: These data might indicate that markers of oxidative stress and ED are altered in diabetic patients without clinical macrovascular complications.
AIMS: To evaluate the relationship between oxidative stress and endothelial dysfunction (ED) in diabeticpatients without clinical macrovascular complications. METHODS: In 27 type 1, 56 type 2 diabeticpatients and 35 healthy controls the redox state (GSH, GSSG; enzymatic method), endothelin-1 (ET-1; ELISA) and von Willebrand factor (vWF; ELISA) plasma levels, urinary vascular endothelial growth factor (VEGF; ELISA) were measured. RESULTS: Decreased GSH levels (p<0.05, type 1 and type 2), GSH/GSSG ratio (p<0.05 type 1, p<0.001 type 2) and elevated vWF levels (p<0.001, type 1 and type 2) were observed in diabeticpatients in comparison with controls. A negative correlation between GSH and vWF (p<0.02 and p<0.001, in type 1 and type 2, respectively) and GSH and BMI (p<0.02 in type 1 and type 2) was observed. ET-1 was positively correlated to age (p<0.05) and diabetes duration (p<0.03) in type 1, while vWF was correlated to systolic blood pressure (p<0.05) in type 2 diabeticpatients. Urinary VEGF was higher in type 2 (p<0.05) in comparison with type 1 diabeticpatients and was correlated to glycemia (p<0.05) and systolic blood pressure (p<0.05). CONCLUSIONS: These data might indicate that markers of oxidative stress and ED are altered in diabeticpatients without clinical macrovascular complications.
Authors: Magdalena A Szkudlinska; Anize D von Frankenberg; Kristina M Utzschneider Journal: J Diabetes Complications Date: 2016-02-05 Impact factor: 2.852
Authors: Meghan F Hogan; Amy W Liu; Michael J Peters; Joshua R Willard; Zaheen Rabbani; Erik C Bartholomew; Adam Ottley; Rebecca L Hull Journal: Endocrinology Date: 2017-02-01 Impact factor: 4.736
Authors: Ricardo Saban; Marcia R Saban; Julie Maier; Ben Fowler; Mark Tengowski; Carole A Davis; Xue-Ru Wu; Daniel J Culkin; Paul Hauser; Joseph Backer; Robert E Hurst Journal: Am J Physiol Renal Physiol Date: 2008-09-24
Authors: Ryan D Bradley; Annette L Fitzpatrick; David R Jacobs; Duk-Hee Lee; Nancy Swords Jenny; David Herrington Journal: Atherosclerosis Date: 2014-01-21 Impact factor: 5.162